Welcure Drugs and Pharmaceuticals Limited (BOM:524661)

BOM:524661 Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	3,655	245.5	-	-	1.05	1.33
Revenue Growth (YoY)	1389.00%	-	-	-	-21.26%	61.63%
Cost of Revenue	3,229	205.05	-	-	-	-
Gross Profit	426.97	40.45	-	-	1.05	1.33
Selling, General & Admin	3.43	4.47	1.03	0.42	0.13	0.77
Other Operating Expenses	-14.43	8.11	-2.25	-0.87	0.68	0.01
Operating Expenses	-10.9	12.65	-0.86	-0.41	0.81	0.78
Operating Income	437.87	27.8	0.86	0.41	0.24	0.55
Interest & Investment Income	-	-	0.58	0.44	-	0
Other Non Operating Income (Expenses)	-	-	0.01	-	-	-0
EBT Excluding Unusual Items	437.87	27.8	1.45	0.86	0.24	0.55
Gain (Loss) on Sale of Investments	-	-	-3.2	0.16	-	-
Pretax Income	437.87	27.8	-1.75	1.02	0.24	0.55
Income Tax Expense	113.07	6.1	-	-	-	-
Net Income	324.81	21.7	-1.75	1.02	0.24	0.55
Net Income to Common	324.81	21.7	-1.75	1.02	0.24	0.55
Net Income Growth	2143.30%	-	-	331.31%	-57.24%	-
Shares Outstanding (Basic)	845	859	149	148	133	133
Shares Outstanding (Diluted)	845	859	149	148	133	133
Shares Change (YoY)	22.17%	477.75%	0.54%	10.90%	-	-
EPS (Basic)	0.38	0.03	-0.01	0.01	0.00	0.00
EPS (Diluted)	0.38	0.03	-0.01	0.01	0.00	0.00
EPS Growth	1736.27%	-	-	284.56%	-57.25%	-
Free Cash Flow	-1,233	-2,220	-1.28	1.07	0.19	0.42
Free Cash Flow Per Share	-1.46	-2.59	-0.01	0.01	0.00	0.00
Gross Margin	11.68%	16.48%	-	-	100.00%	100.00%
Operating Margin	11.98%	11.32%	-	-	22.46%	41.26%
Profit Margin	8.88%	8.84%	-	-	22.46%	41.36%
Free Cash Flow Margin	-33.73%	-904.46%	-	-	17.67%	31.64%
EBITDA	437.97	27.88	1.22	0.44	-	-
EBITDA Margin	11.98%	11.36%	-	-	-	-
D&A For EBITDA	0.09	0.08	0.36	0.03	-	-
EBIT	437.87	27.8	0.86	0.41	0.24	0.55
EBIT Margin	11.98%	11.32%	-	-	22.46%	41.26%
Effective Tax Rate	25.82%	21.94%	-	-	-	-
Revenue as Reported	3,674	264.6	0.94	2.37	1.05	1.34
Advertising Expenses	-	0.07	-	0.02	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.